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Ventilator-associated pneumonia
Background: We evaluated the practices used in Thai hospitals to prevent catheter-associated urinary 
tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), and 
ventilator-associated pneumonia (VAP).
Methods: From January 1, 2014-November 30, 2014, we surveyed all Thai hospitals with an intensive 
care unit and at least 250 beds. The use of prevention practices for CAUTI, CLABSI, and VAP was as-
sessed. High compliance (≥75%) with all components of the CLABSI and VAP prevention bundles were 
determined. CAUTI, CLABSI, and VAP infection rates before and after implementing infection control prac-
tices are reported. Multivariable regression was used to examine associations between infection prevention 
bundle compliance and infection rate changes.
Results: Out of 245 eligible hospitals, 212 (86.5%) responded. A total of 120 (56.6%) and 115 hospitals 
(54.2%) reported ≥75% compliance for all components of the CLABSI and VAP prevention bundles, re-
spectively, and 91 hospitals (42.9%) reported using ≥ 4 recommended CAUTI-prevention practices. High 
compliance with all of the CLABSI and VAP bundle components was associated with significant infec-tion 
rate reductions (CLABSI, 38.3%; P < .001; VAP, 32.0%; P < .001). Hospitals regularly using ≥ 4 CAUTI-
prevention practices did not have greater reductions in CAUTI (0.02%; P = .99).
Conclusions: Compliance with practices to prevent hospital infections was suboptimal. Policies and in-
terventions promoting bundled approaches may help reduce hospital infections for Thai hospitals.
In Southeast Asia, the risk of health care-associated infection (HAI)
is higher than in developed countries with infection related to in-
vasive medical devices remaining a major challenge.1 Several factors
are associated with a high incidence of hospital infection in South-
east Asian countries, including limited resources in most hospitals,
lack of support for infection control from administration, inade-
quate nurse to patient ratios, limited spending on HAI prevention,
as well as limited national policies to help prevent infection.1-3
The need to increase awareness of HAI prevention has been rec-
ognized among Thai health care professionals since 2007.1
Commitment to the World Health Organization Patient Safety Cam-
paign has led to several hospital initiatives to prevent hospital
infections throughout the country.4-8 Despite these efforts, there are
potential gaps in translating the existing knowledge of implement-
ing bundles of care for HAI prevention into clinical practice in a
majority of Thai hospitals. In 2010, we conducted an initial nation-
al survey of practices to prevent HAI in hospitals across Thailand.9
Although many infection-prevention practices for HAI were used
infrequently, hospitals participation in an HAI collaborative network
was associated with more frequent use of certain recommended HAI-
prevention practices from the previous Thai national survey.9 To
understand the current practices used to prevent HAI and develop
further insights into the potential benefits of bundled prevention
approaches, we conducted a follow-up national survey. We were
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especially curious to examine the extent to which compliance with
prevention bundles influence common infections.
METHODS
Survey instrument
From January 1, 2014-November 30, 2014, we surveyed all hos-
pitals in Thailand that had an intensive care unit and at least 250
hospitals beds (N = 245). The list of included hospitals was ob-
tained from the Thai Ministry of Public Health. The survey instrument
was first developed by Krein, et al10,11 and has undergone multiple
recent revisions. The survey was translated into Thai by an expe-
rienced hospital epidemiologist (AA). The survey assessed general
hospital, personnel, and infection control program characteristics,
as well as the practices used by Thai hospitals to prevent common
hospital infections, including catheter-associated urinary tract in-
fection (CAUTI), central line-associated bloodstream infection
(CLABSI), and ventilator-associated pneumonia (VAP).
The lead infection preventionist (IP) for each hospital was in-
terviewed to determine various hospital characteristics, as well as
the frequency of numerous infection-prevention practices being used.
IPs were asked about how often their hospital used specific pre-
vention practices (1 = never to 5 = always) for CAUTI, CLABSI, and
VAP. Responses of 4 or 5 were coded as “regular use” and the di-
chotomized variables were used in all analyses. The level of
compliance with bundled approaches for CLABSI and VAP preven-
tion were also assessed. Hospitals were asked how often they
complied with the given bundled practices (1 = 100% to 6 = no moni-
toring of compliance). Responses of 1 or 2 (75%-100%) were coded
as frequent compliance for all analyses. The CLABSI bundle con-
sisted of hand hygiene, maximum sterile barrier precautions, use
of chlorhexidine gluconate for antisepsis of the insertion site, choos-
ing optimal site for line insertion, and daily review of line necessity.
The VAP bundle consisted of hand hygiene, semirecumbent posi-
tioning of the patient, avoidance of frequent ventilator circuit
changes, use of antimicrobial mouth rinse, feeding content check,
and cross-contamination prevention. Because a specific CAUTI bundle
was not yet promulgated in Thailand, we examined the influence
of regularly using at least 4 of 6 evidence-based CAUTI-prevention
practices: portable bladder ultrasound, urinary catheter reminder/
stop order or nurse-initiated urinary catheter discontinuation,
condom catheters in men, aseptic technique during indwelling
urethral catheter insertion and maintenance, intermittent catheter-
ization, and maintaining a closed urinary catheter system. In addition
to prevention practices, IPs were also asked about their specific hos-
pital HAI infection rates. Data on hospital CAUTI, CLABSI, and VAP
infection rates both 12 months before and 12 months after imple-
menting infection control practices to prevent each infection type
were collected based on the existing infection control data main-
tained at each hospital.
In-person interviews were administered by research nurses who
used the survey instrument to interview each of the lead IPs. Three
training sessions were held to instruct the 5 research nurses on the
survey and data collection procedures. The survey instrument was
pilot tested in 10 hospitals to ensure the validity, reliability, and ac-
ceptability of the survey results by 5 research nurses; 100%
agreement in the responses captured was observed in the pilot test.
This study was approved by the Institutional Review Board of the
Faculty of Medicine, Thammasat University.
Statistical analysis
Descriptive statistics were calculated for all relevant survey ques-
tions. Multivariable logistic regression was used to determine
significant associations between hospital characteristics and regular
use of each infection-prevention practice. The hospital character-
istics considered were type of ownership, number of acute care beds,
affiliation with medical school, whether or not the hospital has
hospitalists, involvement in a collaborative to reduce HAI, support
for an infection control program from leadership, whether or not
the hospital has a hospital epidemiologist, total full-time equiva-
lent of all IPs, and whether the lead IP is certified in infection control.
Additionally, whether or not the hospital has an infectious
diseases specialist, environmental cleaning service, facilities main-
tenance department, or microbiology lab were also included if they
were statistically significant in a bivariable model. One CAUTI prac-
tice (ie, portable bladder ultrasound) was excluded from the logistic
regression analyses due to low use (<5% regular use).
Linear regression models were used to look at relative reduc-
tions in HAI rates. The primary exposure variables were regular use
of 4 of 6 recommended CAUTI practices (for the CAUTI model), at
least 75% compliance with practicing all components of the bundle
for CLABSI (for the CLABSI model), and at least 75% compliance with
practicing all components of the bundle for VAP (for the VAP model).
In addition to the covariates mentioned above in the logistic re-
gression analyses, the relative reduction models were additionally
adjusted for whether or not the hospital has an established sur-
veillance system for monitoring infection rates. All statistical analyses
were performed using SAS version 9.4 (SAS Institute Inc, Cary, NC).
RESULTS
Of the 245 eligible hospitals, 212 (86.5%) responded to our survey.
General and infection-specific characteristics of the hospitals are
in Table 1. Nearly 97% of hospitals reported having hospitalists, 94.8%
have a microbiology lab, and 92.5% have a lead IP who is certified
in infection control. Approximately half of all hospitals were affili-
ated with a medical school (52.4%), have infectious disease specialists
(50.9%), and are involved in a collaborative to reduce HAIs (49.5%).
For CAUTI, more than 90% of responding hospitals have a system
to monitor which patients have a urinary catheter placed (92.9%),
routinely monitor duration/discontinuation of urinary catheters
(90.6%), have an established surveillance system for monitoring
CAUTI rates (96.7%), and report CAUTI rates to direct care provid-
ers (93.9%). Similarly, for CLABSI and VAP, the vast majority of
hospitals have an established surveillance system for monitoring
rates (91.5% for both) and report rates to direct care providers (87.7%
and 90.1%, respectively).
The percentage of hospitals that regularly use key prevention
practices for CAUTI, CLABSI, and VAP are listed in Figure 1. The most
frequently used CAUTI prevention practices among Thai hospitals
were using a closed urinary catheter system (90.1% regular use) and
aseptic technique during indwelling urethral catheter insertion and
maintenance (89.6%). For CLABSI, chlorhexidine gluconate for an-
tisepsis of the insertion site (73.6%) and maximum sterile barrier
precautions during catheter insertion (63.2%) were the most common
prevention practices. For VAP, semirecumbent positioning (86.8%)
and antimicrobial mouth rinse (78.3%) were most frequently used.
A total of 120 (56.6%) hospitals reported ≥75% compliance rate for
all components of the CLABSI prevention bundle and 115 hospi-
tals (54.2%) reported ≥75% compliance rate for all components of
the VAP prevention bundle. Although a specific CAUTI prevention
bundle was not yet recommended, 91 hospitals (42.9%) reported
using ≥ 4 CAUTI-prevention practices.
Significant associations between hospital characteristics and
regular use of various HAI prevention practices use can be found
in Table 2. Hospitals with strong leadership support for infection
control were more likely to use semirecumbent positioning of the
patient, antimicrobial mouth rinse, and oscillating/kinetic beds for
VAP prevention, as well as using chlorhexidine gluconate for in-
sertion site antisepsis and avoiding the femoral site for line insertions
for CLABSI prevention. Hospitals that were involved in an HAI col-
laborative were more likely to regularly use antimicrobial dressing
with chlorhexidine and avoid the femoral site for line insertions for
CLABSI prevention, as well as semirecumbent positioning and an-
timicrobial mouth rinse for VAP prevention. Hospitals that have a
hospital epidemiologist were more likely to regularly use urinary
catheter reminder or stop-order or nurse-initiated catheter discon-
tinuation, antimicrobial catheters, and condom catheters in men for
CAUTI prevention. Having a lead IP certified in infection control was
associated with more regularly using antimicrobial dressing with
chlorhexidine for CLABSI prevention, as well as semirecumbent po-
sitioning of the patient and antimicrobial mouth rinse for VAP
prevention.
Multivariable linear regression results for HAI rate relative re-
ductions can be found in Table 3. Participating in an HAI collaborative
was associated with significant decreases in CAUTI, CLABSI, and VAP
rates (13.4%, 19.2%, and 23.3% reductions, respectively). The pres-
ence of facilities maintenance department was associated with
significant decreases in CAUTI, CLABSI, and VAP rates (18.7%, 13.7%,
and 15.0% reductions, respectively). High compliance (≥75%) with
all of the components of the CLABSI and VAP bundles was also as-
sociated with significant decreases in their respective rates (CLABSI,
38.3% reduction and VAP, 32.0% reduction). Regular use of 4 of 6
recommended CAUTI practices was not associated with decreased
CAUTI rates (0.02% reduction; P = .99).
DISCUSSION
Several key findings emerged from our national Thai study. First,
despite having committed to the World Health Organization Patient
Safety Campaign since 2007, practices to prevent major hospital in-
fections are still practiced infrequently in Thailand. Second, despite
suboptimal use of certain infection-prevention practices, we did iden-
tify several key hospital factors associated with increased use of
numerous HAI-prevention practices. Third, our study supports the
role of HAI care bundles and the need to have a high compliance
level for bundle use to achieve reduction in HAIs in this middle-
income country.
National surveys of practices to prevent HAI—using similar
instruments—have previously been conducted in several coun-
tries, including the United States, Thailand, and Japan.9,12-16 Compared
with the United States, practices to prevent HAI have generally been
used less frequently in Asian countries.9,16 Despite this, the pres-
ence of a strong organizational safety culture has been shown to
improve HAI prevention efforts in Thailand and Japan9,16 and par-
ticipating in an HAI collaborative network has a strong association
with improved HAI prevention in Thailand.9 Similarly, in this study
we found that being involved in a collaborative and having the
support of leadership are important factors associated with higher
use of infection-prevention practices. Additionally, we also found
that having a hospital epidemiologist on staff was associated with
more regular use of several key infection-prevention practices. This
association may be in part explained by the curriculum created by
Thai government to provide formal training for postgraduate phy-
sicians in infection prevention to become a hospital epidemiologist.
This finding highlights an opportunity for countries in Asia to provide
formal training in hospital epidemiology as part of strategic infection-
prevention plans.
Bundles of care are now encouraged for use to prevent infec-
tions throughout the world.17-20 Previous studies in the United States
have shown the positive influence that complying with any 1 of 3
CLABSI bundle elements or complying with 2 VAP bundle compo-
nents had on reductions in CLABSI and VAP rates, respectively.21,22
In this study, we found that achieving high compliance (≥75%) with
all components of prevention care bundles was associated with re-
duction in CLABSI and VAP rates. Our findings thus suggest that strict
adherence to all HAI bundle components may hold promise for
further reductions in HAI outcomes in Thailand. Because there was
no existing CAUTI bundle in Thailand at the time of survey, the in-
fluence of a CAUTI bundle as well as the compliance level needed
to achieve reduction in CAUTI rates cannot be determined. However,
hospitals that more frequently used a combination of numerous
CAUTI prevention practices did not demonstrate greater reductions
in their CAUTI rates, compared with hospitals using fewer practices.
Table 1













Total number of acute care hospital beds (including ICU) 545.9 ± 468.5
Affiliated with medical school 111 (52.4)
Facility has infectious diseases specialist(s) 108 (50.9)
Facility has environmental health and safety/services 130 (61.3)
Facility has facilities maintenance department 144 (67.9)
Facility has a microbiology laboratory 201 (94.8)
Facility has hospitalists 205 (96.7)
Involved in HAI collaborative 105 (49.5)
Overall support for infection prevention and control program is
good or excellent
135 (63.7)
Facility has hospital epidemiologist 83 (39.2)
Total FTE for all infection preventionists 3.5 ± 3.4
Lead IP certified in infection control 196 (92.5)
CAUTI-specific
Regular use of at least 4 of 6 recommended CAUTI-prevention
practices
91 (42.9)
Facility has system for monitoring which patients have UC
placed
197 (92.9)
Facility routinely monitors duration/discontinuation of UCs 192 (90.6)
Established surveillance system for monitoring UTI rates 205 (96.7)
Report UTI rates to direct care providers 199 (93.9)
Baseline CAUTI rates (per 1,000 catheter-days) 4.62 ± 3.5
Post implementation CAUTI rates (per 1,000 catheter-days) 2.85 ± 2.7
CLABSI-specific
At least 75% compliance rate for all components of the bundle
for CLABSI prevention
120 (56.6)
Have CVC insertion checklists 152 (71.7)
Use standardized kits or carts for CVC insertion 135 (63.7)
Conduct daily rounds to assess the ongoing necessity of CVCs 160 (75.5)
Established surveillance system for monitoring CLABSI rates 194 (91.5)
Report CLABSI rates to direct care providers 186 (87.7)
Baseline CLABSI rate (per 1,000 catheter-days) 3.98 ± 2.8
Postimplementation CLABSI rates (per 1,000 catheter-days) 2.52 ± 2.4
VAP-specific
At least 75% compliance rate for all components of the bundle
for VAP prevention
115 (54.2)
Facility encourages early mobilization of ventilated patients
to prevent VAP
186 (87.7)
Established surveillance system for monitoring VAP rates 194 (91.5)
Report VAP rates to direct care providers 191 (90.1)
Baseline VAP rates (per 1,000 ventilator-days) 7.05 ± 4.8
Postimplementation VAP rates (per 1,000 ventilator-days) 4.65 ± 3.4
NOTE. Values are presented as n (%) or mean ± standard deviation.
CAUTI, catheter-associated urinary tract infection; CLABSI, Central line-associated
bloodstream infection; CVC, central venous catheter; FTE, full-time equivalent; HAI,
health care-associated infection; ICU, intensive care unit; UC, urinary catheter; VAP,
ventilator-associated pneumonia.
Several limitations of our study merit discussion. First, because
the response rate was <100%, our results are susceptible to
nonresponse bias. Although we achieved a very high response rate,
our findings may not be generalizable to all hospitals in Thailand.
Second, because we relied on self-reported data from lead IPs to
determine the frequency of the various infection-prevention prac-
tices being used, there is a potential for respondent bias. Third,
hospital infection rates at 2 time points (aggregate 12 months before
and 12 months after interventions were introduced) were based on
reported estimates from the lead IP at each hospital. Absent lon-
gitudinal infection rate data, reported rates in our study are prone
to response bias. Fourth, several infection-prevention practices were
used infrequently, limiting our ability to investigate their influ-
ence on reducing HAI rates directly. Fifth, because the compliance
Fig 1. Percentage of reporting hospitals regularly using select health care-associated infection practices.
Table 2
Multivariable logistic regression results: Factors significantly associated with more frequent use of prevention practices
Infection Practice Variable Odds ratio 95% Confidence interval P value
CAUTI Urinary catheter reminder or stop-order/nurse initiated
catheter discontinuation
Facility has hospital epidemiologist 2.604 1.406 4.824 .002
Antimicrobial catheter Facility has hospital epidemiologist 4.718 1.610 13.820 .005
Condom catheters in men Facility has hospital epidemiologist 2.006 1.049 3.836 .04
Keeping urinary catheter in closed system Number ICU beds 0.989 0.980 0.999 .02
CLABSI Chlorhexidine gluconate for antisepsis of the insertion site Support of IC program from leadership 2.113 1.087 4.107 .03
Antimicrobial catheters Total FTE for all IPs 1.133 1.004 1.278 .04
Antimicrobial dressing with chlorhexidine Involved in HAI collaborative 2.426 1.266 4.648 .01
Lead infection preventionist certified in IC 5.701 1.314 24.739 .02
Avoidance of the femoral site for line insertions Involved in HAI collaborative 2.137 1.122 4.072 .02
Support of IC program from leadership 2.038 1.116 3.723 .02
VAP Semirecumbent positioning of the patient Involved in HAI collaborative 4.354 1.371 13.831 .01
Support of IC program from leadership 2.511 1.020 6.177 .05
Lead infection preventionist certified in IC 5.740 1.464 22.506 .01
Antimicrobial mouth rinse Involved in HAI collaborative 3.497 1.486 8.228 .004
Support of IC program from leadership 2.899 1.359 6.184 .006
Lead infection preventionist certified in IC 4.409 1.137 17.097 .03
Subglottic secretion drainage Type of ownership
Private 0.668 0.269 1.659 .38
Government-owned Reference
Military 3.145 1.036 9.541 .04
Facility has facilities maintenance department 2.159 1.033 4.511 .04
Oscillating/kinetic beds Affiliated with medical school 0.387 0.171 0.876 .02
Support of IC program from leadership 2.342 1.029 5.327 .04
Topical and/or systemic antibiotics for selective
digestive tract decontamination
Type of ownership
Private 0.261 0.087 0.785 .02
Government-owned Reference
Military 0.861 0.280 2.650 .79
Affiliated with medical school 0.404 0.190 0.859 .02
CAUTI, catheter-associated urinary tract infection; CLABSI, central line-associated bloodstream infection; IC, infection control; ICU, intensive care unit; FTE, Full-time equiv-
alent; VAP, ventilator-associated pneumonia.
rates with the CLABSI and VAP care bundles were reported by the
lead IPs and derived from hospital-specific infection control data,
they may not reflect actual compliance. Finally, we did not have
access to (and thus could not adjust for) patient-level or hospital
case-mix data. As such, our regression estimates could be biased
because of unmeasured confounding, and our results can only be
interpreted as providing evidence for associations rather than causal
mechanisms.
CONCLUSIONS
Our study identified several key strategies on which Thai hos-
pitals engaged in infection-prevention efforts should focus. Focusing
on participating in infection-prevention collaboratives, garnering
strong leadership support for infection-prevention efforts, having
a hospital epidemiologist on staff to champion the resources and
buy-in necessary for successful infection control, and promoting cer-
tification in infection control among lead IPs may help in achieving
and sustaining reductions in HAI rates. Although such an infra-
structure shows promise, several gaps still exist between the actual
use of HAI-prevention practices and the national expectations of
patient safety. Importantly, our study highlights the importance of
promoting bundled prevention approaches to help reduce hospi-
tal infections in this developing country. The promotion of best
infection-prevention practices based on expert consensus, poli-
cies for bundled infection-prevention approaches, as well as
dedicated efforts to increase health care workers’ compliance with
such approaches, should be considered as part of focused collab-
orative national efforts to reduce HAI in Thailand.
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